Stock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases

Stock Track

08/15

Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.

H.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.

The overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1110452634"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110452634\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110452634?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-15 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110452634","market":"nz","top_or_hot":-1,"title":"Stock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases","media":"Stock Track","content":"<p>Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.</p>\n\n<p>H.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.</p>\n\n<p>The overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-15 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.</p>\n\n<p>H.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.</p>\n\n<p>The overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SVRA","symbol_name":"Savara Inc","start_time":0,"source_url":"","article_id":"1110452634","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110452634","pubTimestamp":1755264261,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SVRA":"Savara Inc"},"translate_title":"个股追踪|Savara Inc盘前大涨6.32%，多位分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SVRA":1},"content_text":"Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.\nH.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.\nThe overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}